All Stories

  1. New Uracil Analogs with Exocyclic Methylidene Group as Potential Anticancer Agents
  2. Biased Agonism as an Emerging Strategy in the Search for Better Opioid Analgesics
  3. Helenalin - A Sesquiterpene Lactone with Multidirectional Activity
  4. Synthesis of 3-Methylidene-1-tosyl-2,3-dihydroquinolin-4(1H )-ones as Potent Cytotoxic Agents
  5. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif
  6. Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF3-Phe-Asp]NH2
  7. Synthesis, receptor binding studies, optical spectroscopic and in silico structural characterization of morphiceptin analogs with cis -4-amino-L-proline residues
  8. Evaluation of anticancer properties of a new α-methylene-δ-lactone DL-249 on two cancer cell lines
  9. Novobiocin Analogs as Potential Anticancer Agents
  10. ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
  11. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic
  12. Synthesis of linear and cyclic opioid-based peptide analogs containing multipleN-methylated amino acid residues
  13. Anticancer Properties of Novel 4-methylene-1,2-diphenylpyrazolidin-3-ones
  14. Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity
  15. Endless Peptides - Circular Forms in Nature
  16. Proteomic Analysis of Proteins Engaged in α ‐Methylene‐ δ ‐Lactone Cytotoxic Effects in Hormone‐Independent Breast Cancer MDA ‐ MB ‐231 Cells
  17. α-Methylene-γ-lactones as a Novel Class of Anti-leukemic Agents
  18. Combined Effect of Parthenolide and Various Anti-cancer Drugs or Anticancer Candidate Substances on Malignant Cells in vitro and in vivo
  19. Pharmacological Properties of Novel Cyclic Pentapeptides with µ-opioid Receptor Agonist Activity
  20. Bioavailability of Endomorphins and the Blood-brain Barrier- A Review